RIGEL PHARMACEUTICALS INC (RIGL) Net margin 2016–2025
RIGEL PHARMACEUTICALS INC (RIGL) net profit margin by fiscal year — reported net income divided by reported revenue.
124.7%FY2025 · since FY2016: -339.6% → 124.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 124.7% | +115.0 pp |
| FY2024 | 9.8% | +31.2 pp |
| FY2023 | -21.5% | +27.2 pp |
| FY2022 | -48.7% | -36.7 pp |
| FY2021 | -12.0% | +15.4 pp |
| FY2020 | -27.4% | +85.4 pp |
| FY2019 | -112.8% | +45.5 pp |
| FY2018 | -158.3% | +1581.0 pp |
| FY2017 | -1739.3% | -1399.8 pp |
| FY2016 | -339.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice